Nettesheim, P.; Vadodaria, K.C.; Vanover, K.E.; Borghans, L.G.J.M.; Arce, E.; Brubaker, W.; Cunningham, S.; Parks, S.; Serrats, J.; Sudarsan, V.;
et al. Biomarker-Based Pharmacological Characterization of ENX-102, a Novel α2/3/5 Subtype-Selective GABAA Receptor Positive Allo-Steric Modulator: Translational Insights from Rodent and Human Studies. Cells 2025, 14, 1575.
https://doi.org/10.3390/cells14201575
AMA Style
Nettesheim P, Vadodaria KC, Vanover KE, Borghans LGJM, Arce E, Brubaker W, Cunningham S, Parks S, Serrats J, Sudarsan V,
et al. Biomarker-Based Pharmacological Characterization of ENX-102, a Novel α2/3/5 Subtype-Selective GABAA Receptor Positive Allo-Steric Modulator: Translational Insights from Rodent and Human Studies. Cells. 2025; 14(20):1575.
https://doi.org/10.3390/cells14201575
Chicago/Turabian Style
Nettesheim, Pauline, Krishna C. Vadodaria, Kimberly E. Vanover, Laura G. J. M. Borghans, Estibaliz Arce, William Brubaker, Stephen Cunningham, Stephanie Parks, Jordi Serrats, Vikram Sudarsan,
and et al. 2025. "Biomarker-Based Pharmacological Characterization of ENX-102, a Novel α2/3/5 Subtype-Selective GABAA Receptor Positive Allo-Steric Modulator: Translational Insights from Rodent and Human Studies" Cells 14, no. 20: 1575.
https://doi.org/10.3390/cells14201575
APA Style
Nettesheim, P., Vadodaria, K. C., Vanover, K. E., Borghans, L. G. J. M., Arce, E., Brubaker, W., Cunningham, S., Parks, S., Serrats, J., Sudarsan, V., Taylor, E., Klaassen, E., Stuurman, F. E., & Jacobs, G. E.
(2025). Biomarker-Based Pharmacological Characterization of ENX-102, a Novel α2/3/5 Subtype-Selective GABAA Receptor Positive Allo-Steric Modulator: Translational Insights from Rodent and Human Studies. Cells, 14(20), 1575.
https://doi.org/10.3390/cells14201575